Non-Center Involving Diabetic Macular Edema Progression in Early Postoperative Period After Phacoemulsification
Condition(s) studied
Investigational drug(s) / intervention(s)
Coloured photography: Coloured photography will be performed preoperatively and at 3 and 6 months postoperatively.
Fluorescein angiography: Fluorescein angiography will be performed preoperatively and at 3 and 6 months postoperatively. The following features will be recorded on each angiography:
Optical coherence tomography: Optical coherence tomography (OCT) scanning will be performed using the optical coherence tomography scanner OCT (OPTOVUE OCT). OCT will be performed preoperatively and at 3 and 6 months postoperatively.
Study summary
This study aims to evaluate the progression of non-center-involving diabetic macular edema in the early postoperative period following phacoemulsification.
Eligibility
Primary outcome measure(s)
- Best Corrected Visual Acuity — 6 months post-procedure
Best Corrected Visual Acuity (BCVA) will be recorded.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Ain Shams University | Cairo | Egypt | Recruiting |
More Ain Shams University trials in Egypt
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07038967 on ClinicalTrials.gov ↗ ← All trials in Egypt